亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Complications after laparoscopic sleeve gastrectomy

医学 外科 袖状胃切除术 并发症 腹腔镜检查 减肥 胃分流术 普通外科 肥胖 内科学
作者
Peter F. Lalor,Olga Tucker,Samuel Szomstein,Raul J. Rosenthal
出处
期刊:Surgery for Obesity and Related Diseases [Elsevier]
卷期号:4 (1): 33-38 被引量:250
标识
DOI:10.1016/j.soard.2007.08.015
摘要

Laparoscopic sleeve gastrectomy (LSG) has recently become a feasible option in the management of morbid obesity. The objective of this study was to examine the morbidity and mortality arising from LSG as a primary procedure for weight loss.We retrospectively reviewed the data of 164 patients who underwent LSG from 2004 to 2007. Patients underwent LSG as a primary procedure or as revisional bariatric surgery. The short-term morbidity and mortality were examined.One-stage LSG was performed in 148 patients. The major complication rate was 2.9% (4 of 149), including 1 leak (0.7%) and 1 case of hemorrhage (0.7%)-each requiring reoperation-1 case of postoperative abscess (0.7%), and 1 case of sleeve stricture that required endoscopic dilation (0.7%). One late complication of choledocholithiasis and bile duct stricture required a Whipple procedure. LSG was used as revisional surgery in 16 patients (9%); of these, 13 underwent LSG after complications related to laparoscopic adjustable gastric banding, 1 underwent LSG after aborted laparoscopic Roux-en-Y gastric bypass, and 2 underwent LSG after failed jejunoileal bypass. One of these patients developed a leak and an abscess (7.1%) requiring reoperation. One case was aborted, and 2 cases were converted to an open procedure secondary to dense adhesions. No patient died in either group. All but 3 cases were completed laparoscopically (98%).LSG is a relatively safe surgical option for weight loss as a primary procedure and as a primary step before a secondary nonbariatric procedure in high-risk patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
昭蘅完成签到 ,获得积分10
4秒前
无月完成签到,获得积分10
4秒前
wlei完成签到,获得积分10
5秒前
科研通AI6应助Cindy采纳,获得10
5秒前
脑洞疼应助王文艳采纳,获得10
6秒前
爆米花应助韵寒采纳,获得10
6秒前
Demon应助ceeray23采纳,获得20
9秒前
科研通AI6应助说话的月亮采纳,获得10
9秒前
12秒前
乐乐应助活泼的断秋采纳,获得10
13秒前
山川日月完成签到,获得积分10
14秒前
14秒前
冬柳发布了新的文献求助10
16秒前
传奇3应助科研通管家采纳,获得10
18秒前
在水一方应助科研通管家采纳,获得10
18秒前
小二郎应助科研通管家采纳,获得10
18秒前
小二郎应助科研通管家采纳,获得10
18秒前
浮游应助科研通管家采纳,获得10
18秒前
浮游应助科研通管家采纳,获得10
18秒前
浮游应助科研通管家采纳,获得10
18秒前
小黄还你好完成签到 ,获得积分10
18秒前
mao完成签到,获得积分10
20秒前
乐观摸摸头完成签到 ,获得积分10
20秒前
21秒前
26秒前
William_l_c完成签到,获得积分10
26秒前
29秒前
30秒前
31秒前
周冯雪完成签到 ,获得积分10
33秒前
PDE发布了新的文献求助10
34秒前
NexusExplorer应助暗夜追逐者采纳,获得10
34秒前
范琴琴完成签到 ,获得积分10
38秒前
39秒前
沉静的安青完成签到,获得积分10
43秒前
43秒前
活泼的断秋完成签到,获得积分10
44秒前
雪生在无人荒野完成签到,获得积分10
51秒前
烨枫晨曦完成签到,获得积分10
52秒前
科研通AI6应助pishuang采纳,获得10
55秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
Active-site design in Cu-SSZ-13 curbs toxic hydrogen cyanide emissions 500
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5463110
求助须知:如何正确求助?哪些是违规求助? 4567902
关于积分的说明 14311963
捐赠科研通 4493737
什么是DOI,文献DOI怎么找? 2461864
邀请新用户注册赠送积分活动 1450876
关于科研通互助平台的介绍 1426051